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Abstract 
Background: Preferences of both Alzheimer patients and their spouse caregivers are re-
lated to a willingness-to-pay (WTP) measure which is used to test for the presence of mu-
tual (rather than conventional unilateral) altruism. 
Methods: Contingent valuation experiments were conducted in 2000 – 2002, involving 
126 Alzheimer patients and their caregiving spouses living in the Zurich metropolitan ar-
ea (Switzerland). WTP values for three hypothetical treatments of the demented patient 
were elicited. The treatment Stabilization prevents the worsening of the disease, bringing 
dementia to a standstill. Cure restores patient health to its original level. In No burden, 
dementia takes its normal course while caregiver’s burden is reduced to its level before 
the disease. 
Results: The three different types of therapies are reflected in different WTP values of 
both caregivers and patients, suggesting that moderate levels of Alzheimer’s disease still 
permit clear expression of preference. According to the WTP values found, patients do 
not rank Cure higher than No burden, implying that their preferences are entirely altruis-
tic. Caregiving spouses rank Cure before Burden, reflecting less than perfect altruism 
which accounts for some 40 percent of their total WTP. Still, this constitutes evidence of 
mutual altruism. 
Conclusions: The evidence suggests that WTP values reflect individuals’ preferences 
even in Alzheimer patients. The values found suggest that an economically successful 
treatment should provide relief to caregivers, with its curative benefits being of secondary 
importance. 
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1 Introduction 
Dementia refers to a group of diseases characterized by progressive deterioration in cognitive 
function. According to ICD-10, the international statistical classification of diseases, the 
symptoms are memory loss, disorientation, and inappropriate social behavior. Whereas ICD-
10 distinguishes between four different types of dementia, this paper focuses on Alzheimer’s 
disease, the most common type of dementia. According to Brookmeyer et al. (2007), more 
than 26 million people worldwide suffer from Alzheimer’s disease. About 70 percent of pa-
tients are in need of care, while 60 percent live at home. Therefore, informal care (usually 
provided by the spouse) constitutes the major part of the care received by patients with de-
mentia (Alzheimer Disease International 2012). Providing care for a person with dementia is 
stressful and demanding (Bédard et al. 2000; Whitlatch 1998; Simpson and Carter 2013). 
Hence, caregivers bear not only the opportunity cost of their time devoted to caring but also a 
loss of well-being. Trepel (2011) estimates the cost of informal dementia care in Ireland to 
range between 240 and 570 Euros per day (1 Euro = 1.3 US$ at exchange rates of 2011), de-
pending on the stage of the disease. Therefore, dementia affects not only the patient but also 
the caregiving relative. 
Dementia is a chronic disease, for which currently no cure exists. However, in this paper a 
hypothetical ‘magic cure’ for dementia is postulated in order to experimentally identify and 
estimate altruistic preferences. The objective is to elicit willingness-to-pay (WTP) values for 
different types of this hypothetical cure, which is presented to participants in the experiment 
as having two main benefits. One is to improve the health status of the patient, the other, to 
reduce caregiver burden and time needed to take care for the patient. The first benefit there-
fore accrues to patients, whereas the second, to caregivers. 
There are two basic hypotheses to be tested in this paper. The first states that these two types 
of benefit translate into differences in preferences, measurable as WTP values. The second is 
that WTP values reflect mutual altruism in that patients are willing to sacrifice wealth (by 
purchasing the ‘magic cure’) to ease caregiver’s burden, while caregivers are prepared to do 
the same in order to achieve an improvement in patient well-being. Willingness to sacrifice 
one’s wealth (or time) to the benefit of others falls under almost all definitions of altruism 
advanced in the literature (Simon 1993; Rose-Ackerman 1996; for an economic formulation 
of altruism in a healthcare context, see Arana and Leon 2002). Individuals’ WTP for improv-
ing their own health has been analyzed before (see e.g. Nocera et al. 2002). Also, altruism of 
caregivers towards patients related through kin has been subject of research (see e.g. Byrne et 
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al., 2009). However, to the best of our knowledge, there has not been a study examining mu-
tual altruism, expressed through WTP values. 
The remainder of this paper is organized as follows. The next section contains a review of the 
pertinent literature. This is followed by a presentation of the experimental method used and 
the data obtained. The core section presents the WTP estimates which permit testing the two 
hypotheses advanced in this paper, viz. that preferences can be identified and measured in the 
guise of WTP values also of Alzheimer patients, and that preferences reflect mutual altruism 
both on the part of patients and caregivers. The final section of the paper is devoted to a 
summary and conclusions. 
2 Literature Review 
In health care and especially long-term care, Contingent Valuation (CV) is widely accepted 
and frequently used to measure the value of non-market goods (Diener et al. 1998; Klose 
1999; Olsen & Smith 2001; Gustafsson-Wright et al. 2009). The CV method is based on ask-
ing persons directly about the amount of money they are willing to pay for a reduction in their 
risk of illness or death or for an improvement in their quality of life. Generally, the aim is to 
identify a subjective trade-off: How much income or wealth is someone prepared to sacrifice 
in return for the health benefit proposed? In economic terms, respondents are made to move 
along their indifference curves, with an indifference curve defining the locus where their (ex-
pected) utility is kept constant (Shiell and Rush 2003). The underlying theory is that individu-
als are optimizers, i.e. utility maximizers subject to constraints imposed by income, wealth, or 
time. However, this formulation does not exclude the possibility of utility also depending on 
the well-being of someone else rather than just one’s own. This is compatible with self-
interest as long as the individual considered wants to retain the right to decide how much of 
his or her own resources are to be devoted to another person and who this person is to be 
(Becker 1976, Sen 1973). In this sense, altruism is conditional; it also may be induced by the 
expectation of future reciprocity. Since reciprocity can be excluded for practical reasons in the 
context of Alzheimer’s disease, this literature review focuses on what may be dubbed ‘true’ 
altruism. 
‘True’ altruism can be defined as warm glow (Andreoni, 1995), meaning that it is induced by 
the good conscience caused by engaging in an activity that is approved by society. Fehr and 
Schmidt (2006) define altruism as the utility gain derived from helping others. However, note 
that in their formulation, even ‘true’ altruism is conditional because it turns into envy (reflect-
ing a loss in utility) as soon as the potential donor is worse off than the potential recipient. 
3 
Since utility gains can be expressed in positive WTP values, altruism will be identified in this 
paper with positive WTP for benefits accruing to the other party in the interaction between 
caregiver and patient (Shiell and Rush 2003). Note that according to Fehr and Schmidt 
(2006), negative WTP values cannot be excluded in principle – unless ‘health’ is considered 
as being something different from ‘wealth’, as argued by the proponents of extra-welfarism in 
health (Brower et al., 2008). 
Attempts at identifying and estimating preferences with regard to health come in two catego-
ries. The first deals with an improvement of one’s own health. Since these studies are of lim-
ited relevance to the present paper with its emphasis on altruism, only those directly related to 
Alzheimer’s disease are mentioned here. Nocera et al. (2002) performed a CV experiment 
involving the general population to find out whether three specific programs designed to fight 
Alzheimer’s disease have WTP values that exceed their marginal cost and therefore should be 
implemented from a societal point of view. König and Wettstein (2002) analyze informal 
caregivers’ WTP for relief from their burden, using the same data as this study (see the Data 
subsection below). The high WTP values found point to substantial utility losses on the part 
of informal caregivers. 
Contributions in the second category revolve around altruism between persons related through 
kin. Most of them estimate parents’ WTP for the health of their children (see e.g. Agee & 
Crocker 1996; Liu et al. 2000; Viscusi et al. 1987). For example, Liu et al. (2000) show that a 
mother’s WTP for keeping her child safe from suffering a cold is about twice her WTP for 
avoiding a cold of comparable duration and severity herself. By way of contrast, Schwarze 
(2004) finds but weak evidence of parental altruism regarding children’s health. More recent-
ly, however, Goldberg et al. (2009), examining parents’ WTP for a quality label on infant’s 
milk formula, infer a high degree of parental altruism. In addition, Loomis et al. (2009) use a 
so-called Discrete Choice Experiment (an alternative to CV; see e.g. Louviere et al., 2000) to 
investigate parents’ WTP to reduce health risks to their children. Their estimated WTP values 
point to strong altruism. 
Finally, a study by Byrne et al. (2009) deals with adult children’s provision of informal long-
term care as a potential substitute of formal care. They identify a considerable degree of altru-
ism in adult children with regard to their parents’ health. 
While the literature presented here revolves around unilateral (intergenerational) altruism, this 
study seeks to identify mutually altruistic behavior by estimating WTP values for both care-
givers and patients. Caregivers are hypothesized to be willing to sacrifice some of their in-
come and wealth in order to pay for a cure of their parents’ Alzheimer’s disease; patients are 
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hypothesized to do the same if the cure eases the burden falling on their children as caregiv-
ers. Note that perfectly altruistic individuals fully adopt the beneficiary’s preferences, result-
ing in WTP values that are identical with those of the beneficiaries for themselves. In that 
case, patients are predicted to display the preferences of caregivers and vice versa. In the case 
of imperfect altruism, WTP values contain one component reflecting the beneficiary’s prefer-
ences and another component reflecting the donor’s own. We are not aware of any other study 
that distinguishes between these two components of WTP in both patients and their caregiv-
ers. 
3 Method 
3.1 Measurement of preferences and of willingness-to-pay (WTP) 
While cost-effectiveness and cost-utility (usually based on quality-adjusted life years QALYs, 
see e.g. Dolan 2000) have become popular concepts in medical science, they suffer from a 
crucial drawback. They cannot answer the policy question, “Should more public resources be 
spent on health care or on education?” For this, cost-benefit analysis is needed, which 
measures both costs and benefits in monetary terms. For goods traded on free markets, the 
price consumers are willing to pay provides a lower bound for their benefit, i.e. the intensity 
of their preferences with regard to the good in question. In the case of non-marketed goods 
(such as medical treatments that do not yet exist), no revealed preferences can be measured. 
Instead, WTP must be inferred from stated preferences expressed with regard to a hypothet-
ical situation created in an experiment. The popular criticism that individuals have unstable 
preferences when it comes to medical care (‘no interest when healthy, willing to sacrifice their 
fortune when ill’) can be shown to be spurious because the alleged instability may be inter-
preted as resulting from state-dependent (objective) capabilities to “produce” consumption 
services and health rather than state-dependent preferences (Zweifel 2001). Therefore, there is 
no a priori argument against measuring WTP for improvements in health status. 
In economics, the traditional approach for measuring WTP has been Contingent Valuation 
(Mitchell and Carson, 1989), where all the attributes of a product are held constant except 
price, while respondents are asked to indicate the maximum amount of money they would be 
willing to sacrifice to obtain the good. This approach is used here (for details, see the subsec-
tion, Survey and WTP questions below). 
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3.2 Hypotheses to be tested 
In the experiment, WTP values for three hypothetical treatments of the demented patient are 
elicited (for their description, see Exhibit). The first (Stabilization) prevents the disease from 
worsening, bringing dementia to a standstill. Interviewers explicitly informed participants that 
the treatment does not lead to any improvement in the health state of the patient. In the second 
case (Cure), participants are asked about their WTP for a hypothetical treatment that restores 
the patient’s health status to its original level. The time required for care and the burden fall-
ing on the caregiver are reduced to the level prior to the onset of the disease. In the third case 
(No burden), dementia takes its normal course while caregiver burden returns to its level be-
fore the onset of the disease. 
Exhibit: Elements of the Questionnaire 
 
Stabilization: Imagine that further cognitive impairment of your spouse could be prevented 
using a very expensive treatment that is not covered by health insurance. Thus there would be 
no further deterioration – but no improvement either! 
Cure: Imagine that the cognitive impairment of your spouse could be reverted using a very 
expensive treatment that is not covered by health insurance, resulting in the situation that ob-
tained before the onset of the illness. 
No burden: Imagine that there are ways not covered by health insurance to reduce your bur-
den caused by the cognitive impairment of your spouse (which might become even more 
marked in the future), resulting in a burden as is usual between healthy partners. 
All treatments: Would you want to opt for this treatment if you had to pay the following 
amounts just once? Please consider that you will have that much less to spend for other pur-
poses! Bids offered: 5000, 10,000, 20,000, 50,000, 100,000, 150,000, 200,000, and 500,000 
Swiss francs. Answers offered: yes, rather yes, not sure, rather no, no. 
All treatments: What percentage of your wealth would you be willing to pay for such a treat-
ment? 
In all three cases, respondents were told that the hypothetical treatment was expensive and not 
covered by health insurance. Therefore, they would have to pay for it out of their pocket. Out-
comes were presented as being certain and due to treatment (rather than e.g. behavioral ad-
justment). 
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Under the counter-hypothesis of egoism on the part of both patients and caregivers, the fol-
lowing rankings of treatments are expected in terms of WTP values. For patients, the predict-
ed ranking is Cure > Stabilization > No burden in view of the implied differences in their 
health status. For caregivers, it is No burden = Cure > Stabilization since No burden and Cure 
offer the same relief to them. 
These rankings may be contrasted to those that obtain if both patients and caregivers are per-
fectly altruistic, causing them to fully adopt the other’s preference structure. This means that 
patients are predicted to display the ranking of caregivers, viz. No burden = Cure > Stabiliza-
tion, and caregivers, the ranking of patients, viz. Cure > Stabilization > No burden. 
3.3 Survey and WTP questions 
The unique data set used in this paper comes from a larger study on ‘Effects of training rela-
tive caregivers of patients with dementia’. It includes only patients in the mild to moderate 
stage of the disease because the training offered to spouse caregivers was thought to be inef-
fective for patients having severe Alzheimer’s. The WTP questions analyzed below were de-
veloped with the help of survey specialists and gerontologists and added on to the existing 
questionnaire of the larger study. A pretest comprising a dozen couples with an Alzheimer 
spouse suggested a few minor adjustments of the questionnaire. Patients and caregivers are 
from the Zurich metropolitan area in Switzerland and were interviewed between September 
2000 and August 2002. Since more than 90 percent of the caregivers are spouses, analysis is 
limited to couples in the interest of increased homogeneity. The sample thus contains 126 
pairs of patients with dementia and their spouse caregivers. 
The WTP information comes from face-to-face interviews with patients and their caregivers. 
Caregivers and their demented relatives were interviewed separately and contemporaneously 
by a study nurse and a physician, respectively. They had to state their WTP independently of 
each other without any possibility of contact and cooperation. Caregivers and patients an-
swered the same questions, involving identical treatments and offered bids. No randomization 
of bids to prevent sequencing effects was performed because the possible biases would be 
similar in the two groups. Such biases should therefore be of limited relevance when the ob-
jective is to compare the WTP values of patients and caregivers. 
The questions about WTP were put in two different ways. First, a payment card format was 
used, with prices of 5,000, 10,000, 20,000, 50,000, 100,000, 150,000, 200,000, and 500,000 
Swiss francs (CHF; 1 CHF = 0.7 US$ at 2002 exchange rates) for every hypothetical treat-
ment. The second way to obtain WTP information was to directly ask respondents to state the 
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maximum percentage of their wealth they were willing to give up for buying able to pay for 
the hypothetical treatment. This sequence of the two approaches was chosen because several 
studies had shown that the use of payment cards serves to reduce the number of non-
responses and protest responses compared to directly asking respondents for their WTP 
(Klose 1999). 
The wealth share is the preferred measure because it puts a limit imposed by ability to pay on 
stated WTP values. Such a limit is of importance when WTP values tend to be inflated, which 
is to be expected in the present context (Chiu et al. 1998). Thus, WTP expressed as a percent-
age of wealth will be used (results in terms of absolute amounts of money are quite similar). 
However, note that none of the absolute WTP values was negative, suggesting that ‘health’ 
indeed differs from ‘wealth’ when it comes to altruism (see the section, Literature review 
again) 
3.4 Data 
A mere 36 percent of patients are female. This low percentage results from the fact that only 
patients living at home and cared for by relatives were included in the study. Patient age rang-
es from 52 to 91, with a mean of 75 years. The youngest caregiver is 42 and the oldest, 90 
years old, with mean age at 71 years. On average, patients thus are four years older than their 
caregivers. Some 31 percent of patients have a Clinical Dementia Rating (CDR) score exceed-
ing six. The CDR is a measure of impairment (Hughes, Berg & Danzinger, 1982), has scores 
ranging from 0 to 18, and is widely used in studies to gauge the severity of dementia. 
Household wealth ranges from zero to CHF 10 million. Mean and median wealth are CHF 
614,000 (US$ 430,000) and CHF 300,000 (US$ 210,000), respectively, indicating considera-
ble skewness in the distribution of household wealth. 
4 Empirical Evidence 
4.1 Results 
Only couples both of whom answered the WTP questions are included in the analysis. There-
fore, there is a one-to-one relationship between patients and caregivers. 
Table 1 shows results for mean and median WTP, measured as a share of household wealth. 
To just prevent future worsening of their disease (Stabilization), the Alzheimer patients sam-
pled are willing to sacrifice an average of 14 percent of their wealth, to be completely cured 
(Cure), an average of 22 percent, and to obtain relief for their caregivers (No burden), 22 per-
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cent. The corresponding values for caregivers amount to 24 percent for Stabilization, 31 per-
cent for Cure, and 18 percent for No burden, respectively. Differences between the three 
treatments therefore are clearly reflected in intuitive differences in WTP values, mirroring 
preferences not only among caregivers but also Alzheimer patients. 
Table 1: Willingness to pay expressed in percentage of wealth 
  (1) 
Stabilization
Testa) 
,    
(2) 
Cure 
Testa) 
,    
(3) 
No 
burden 
Testa) 
,    
Mean Patients 13.8  (1,2)** 21.6  (2,3)* 21.9  (1,3)** 
Caregivers 23.9  (1,2)* 30.7  (2,3)** 17.5  (1,3)* 
Test a)   **   **   n.s.  
Median Patients 10.0  10.0  10.0  
Caregivers 10.0  20.0  10.0  
SD 
(Mean) 
Patients 2.1  2.8  2.9  
Caregivers 2.7  3.0  2.1  
Number of observations 96   95  94  
a) Test for significance of difference,  (horizontal) and  (vertical); *(**) significant at the 0.10 (0.05) level 
or better. 
The WTP values displayed in Table 1 can be compared horizontally, using t tests to determine 
whether the WTP values associated with the three treatments differ significantly. Patient WTP 
for Stabilization is significantly lower than for both Cure (t = 2.22, calculated on the simplify-
ing assumption of zero covariance between WTP values) and No burden (t = 2.26). There is 
no statistical difference between Cure and No burden (t = 0.07). Turning to the caregivers, 
they seem also to value Stabilization less than Cure, although this difference is significant at 
the 0.10 level only (t = 1.68). In contrast to patients, however, they tend to put a higher value 
on Stabilization than on No burden, albeit subject to the same proviso (t = 1.87). 
In order to check whether the emerging differences in preference between patients and care-
givers are in fact significant, a vertical comparison (in Table 1) is performed as well. Indeed, 
patients value Stabilization less highly than caregivers (t = 2.95); interestingly, this also holds 
for Cure (t = 2.16), although Cure is in their primary own interest – an indication of perfect 
altruism. However, with regard to No burden, preferences of patients and caregivers do not 
differ (t=0.35). 
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Observed rankings are juxtaposed with predicted ones in Table 2. Patients rank the three 
treatments exactly as predicted by perfect altruism. In particular, they do not exhibit WTP for 
Cure in excess of No burden. Therefore, patient WTP consists of the altruistic component 
only. As to caregivers, their observed ranking again points to altruism rather than egoism. 
Specifically, caregivers exhibit WTP for Cure in excess of No burden, the excess amounting 
to an altruistic component (WTP for improving patient health). Their total WTP for Cure di-
vides into some 60 percent for the reduction of their own burden (17.5/30.7 in Table 1) and 40 
percent for improving their partner’s health ((30.7 – 17.5)/30.7). Taken together, these results 
can be summarized in the provocative conclusion that a Cure of dementia is only in the inter-
est of caregivers. In order to meet with sufficient willingness to pay, a future treatment would 
therefore have to provide relief to caregivers (No burden) more than anything else, while its 
curative benefits (Cure) would be of secondary importance. 
Table 2: Predicted and actual rankings 
Hypothesis Predicted Observed 
(from Table 1, differences  ) 
WTP of patients 
Egoism Cure > Stabilization > No burden	  
Altruism No burden = Cure > Stabilization No burden = Cure > Stabilization 
WTP of Caregivers 
Egoism No burden = Cure > Stabilization  
Altruism Cure > Stabilization > No burden Cure > Stabilization > No burden 
Note: (>) denotes 0.10 rather than 0.05 significance level 
4.2 Discussion 
In this study, 126 pairs of Alzheimer patients and their spouse caregivers stated their willing-
ness to pay (WTP) for three hypothetical treatments of dementia. A first major result is that 
differences in the benefits of the proposed treatments clearly go along with intuitive differ-
ences in WTP values, suggesting that measured WTP reflects preferences of both caregivers 
and patients, in spite of cognitive impairment due to Alzheimer’s disease among the latter. A 
possible objection to this first conclusion is that the WTP values obtained especially for Cure 
are too low, amounting to less than one-third of wealth on average (see Table 1 again). As 
dementia is a fatal disease, should respondents not be willing to spend their entire wealth for 
curing it? 
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Of course, estimated WTP values may fall short of true values. However, there are several 
reasons for the true values to be less than wealth, in keeping with economic theory (Jones-Lee 
et al. 1985; Thaler and Rosen 1975). First, most patients are old. Therefore, curing dementia 
only means prolonging life for a few years. Second, because of age and other diseases beside 
Alzheimer’s, quality of life during these additional years may be low. Third, all participants in 
this study have a spouse, who on average is four years younger. Spending money on treatment 
thus means reducing the material welfare of the spouse, whose higher remaining life expec-
tancy serves to lower her per-period resources to begin with. Fourth, most of the patients and 
caregivers are retired, usually lacking the possibility to relax their wealth constraint by earn-
ing additional income. During the face-to-face interviews, respondents in fact mentioned 
these considerations when searching for their WTP for the three types of Alzheimer treatment. 
The second main finding is that the structure of the WTP values obtained points to mutual 
altruism. From the literature (see e.g. Liu et al. 2000; Goldberg et al. 2009; Loomis et al. 
2009), unilateral altruism on the part of the (parent) caregiver in favor of the child is an estab-
lished fact. However, the present study suggests the existence of altruism also on the part of 
patients. Their ranking of the three treatments is precisely the one predicted by the altruism 
hypothesis while contradicting the egoism counter-hypothesis (see Table 2 again). Specifical-
ly, patients put No burden first; they worry more about the burden falling on their spouse 
caregivers than their own health. Second, compared to their caregivers, they differ in their 
valuations of the three treatment alternatives in the way predicted by the altruism hypothesis. 
In particular, they are willing to pay the same amount as their caregiving spouses for the No 
burden alternative but less for the Cure and Stabilization options, which clearly would be in 
their self-interest. 
Caregiver altruism is documented by their rankings as well. They put the Cure alternative first 
and No burden last, although the two are equivalent in terms of their own situation (see Ta-
ble 2). 
Of course, hypothetical treatments being associated with hypothetical payments, there is al-
ways scope for stated WTP values to be inflated. This tendency must be expected especially 
when the alternative considered (helping a patient or a caregiver) is socially accepted [leading 
to ‘warm glow’ (Andreoni 1995), ‘yea-saying’ (Blamey et. al. 1999), and starting point bias 
(Carson 2000)]. However, by having to express WTP as a share of their (predetermined) 
wealth, respondents were prevented from grossly overstating their WTP values. One could 
still doubt that either partner of the couple would in fact sacrifice one-third (or even more) of 
his or her fortune to have Alzheimer cured. Possibly, patients’ WTP might be sufficiently 
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inflated to exceed that of caregivers in the case of No burden, creating spurious evidence in 
favor of altruism. However, it is far from clear that this particular effect will result in the 
equivalence element in the ranking No burden = Cure > Stabilization predicted by altruism 
and confirmed by the data (Table 2). On the whole, it seems difficult to explain the full set of 
observed rankings with reference to bias in WTP estimation. 
5 Conclusion 
Alzheimer patients constitute a group in society that importantly depends on informal care. 
Unilateral altruism is a likely motive to provide such care and has also been established in 
parent-child relationships. In the context of Alzheimer disease, however, both patient and 
spouse caregiver are in similar (advanced) age. Their altruism might therefore be mutual, alt-
hough patients cannot express it easily through their activity anymore. 
An experiment involving 126 Alzheimer patients and their caregiving spouses living in the 
Zurich (Switzerland) metropolitan area was conducted in 2000 – 2002 to throw light on this 
issue by confronting them with three hypothetical therapies, Stabilization, Cure, and No bur-
den (for caregivers). The objective was to find out whether preferences are reflected in the 
economic concept of willingness-to-pay (WTP) and to test whether the rankings of WTP val-
ues obtained conform to full mutual altruism, in the sense that the patient adopts the prefer-
ences of the caregiver and vice versa. 
The WTP values derived from the experiment consistently reflect differences in the benefits 
associated with the three treatments, suggesting that they do mirror preferences also of pa-
tients suffering from moderate Alzheimer’s disease. Also, these WTP values exhibit rankings 
that conform to the altruism hypothesis but contradict the egoism hypothesis both for patients 
and caregivers. First, patients rate No burden and Cure as equivalent (although No burden 
would not improve their health), while caregivers have maximum WTP for Cure (although 
this would not benefit them more than No burden). Second, caregivers and patients are pre-
pared to pay the same amount for No burden, whereas caregivers value Cure (which would be 
in the interest of patients) higher than patients themselves. The startling implication is that 
curing Alzheimer’s disease would benefit caregivers rather than patients. Therefore, to be 
economically successful, any future treatment of Alzheimer’s disease would (in the interest of 
both patients and caregivers) have to reduce the burden of caregivers; its curative benefit 
would be of secondary importance. 
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